<DOC>
	<DOCNO>NCT02942914</DOCNO>
	<brief_summary>This trial conduct evaluate safety study drug give injection skin healthy participant participant type 2 diabetes . It also investigate body process study drug effect study drug blood sugar level . Information side effect tolerability document . This study approximately 30 day participant , include screen . Screening require within 28 day prior start study .</brief_summary>
	<brief_title>A Study LY3209590 Healthy Participants Participants With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>For study participant : Must male , female become pregnant , either healthy participant , type 2 diabetes least 1 year Male participant female partner become pregnant must agree use effective method birth control study 4 month study drug dose Have body mass index ( BMI ) great 18.5 kilogram per square meter ( kg/m² ) less equal 35 kg/m² screen Have blood pressure , pulse rate , blood urine laboratory test result acceptable study Have venous access sufficient allow blood sample For participant Type 2 Diabetes Mellitus ( T2DM ) : Have T2DM control diet exercise alone stable metformin least 30 day If take , prescription medication medical condition ( e.g.antihypertensive agent , aspirin lipid lower agent ) stable least 4 week Have hemoglobin A1c ( HbA1c ) great equal 7.0 % less equal 9.5 % For study participant : Are currently participate another clinical study Have history multiple and/or severe allergy drug food history severe anaphylactic reaction Have use health problem laboratory test result electrocardiogram ( ECG ) reading , opinion doctor , could make unsafe participate could interfere understand result study Have donate blood loss 500 milliliter ( mL ) last 3 month blood donation within last month screen Intend start new overthecounter prescription medication 7 14 day plan dose For participant T2DM : Have take glucoselowering medication , metformin , include insulin , past 3 month screen Have 1 episode severe hypoglycemia , within 6 month entry study , history hypoglycemia unawareness poor recognition hypoglycemic symptom Have blood transfusion severe blood loss past 3 month , blood disorder could interfere understand result study Have receive chronic ( last great 14 consecutive day ) systemic glucocorticoid therapy ( exclude topical , intraarticular , inhaled preparation ) 3 past month , receive glucocorticoid therapy within 30 day screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>